MSLE is Satellos Bioscience Inc. (Healthcare) — a non-dividend-paying stock. Trading at $8.97. Market cap: $193M.
Stock snapshot
| Price | $8.97 |
| Market cap | $193M |
| Sector | Healthcare |
| Exchange | NGM |
| Pays dividend | No |
About MSLE
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
Related non-dividend companies
Other non-dividend stocks investors research alongside MSLE. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is MSLE's current stock price?
MSLE (Satellos Bioscience Inc.) is currently trading at $8.97.
Does MSLE pay a dividend?
MSLE (Satellos Bioscience Inc.) does not currently pay a regular dividend.
Track MSLE in DiviDrip
Add MSLE to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search MSLE and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.